22q11.2 deletion syndrome (22q11.2DS) is associated with high rates of anxiety disorders, psychotic disorders, and other psychiatric conditions. In the general population, psychiatric disorders are treated with proven pharmacological and non-pharmacological therapies, such as cognitive behavioral therapy (CBT). To begin to assess the feasibility and efficacy of non-pharmacological therapies in 22q11.2DS, we performed a systematic search to identify literature on non-pharmacological interventions for psychiatric disorders in individuals with 22q11.2DS. Of 1,240 individual publications up to mid-2016 initially identified, 11 met inclusion criteria. There were five literature reviews, five publications reporting original research (two originating from a single study), and one publication not fitting either category that suggested adaptations to an intervention without providing scientific evidence. None of the original research involved direct study of the evidence-based non-pharmacological therapies available for psychiatric disorders.
Prominent features include congenital anomalies, endocrine disorders, intellectual and developmental disabilities, and early onset and later onset psychiatric conditions. Three in five adults with the syndrome will develop one or more psychiatric disorders in their lifetime (Fung et al., 2010) . More specifically, anxiety disorders are reported in approximately 30% of adolescents and adults with 22q11.2DS, and psychotic disorders are seen in about 30% of adults (Schneider et al., 2014 ) (when ascertainment is not taken into account).
In the general population, psychiatric disorders such as anxiety disorders, and schizophrenia and other psychotic disorders, are effectively treated with both pharmacological and non-pharmacological therapies. For anxiety in particular, the latter can include cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT).
Recommendations for these non-pharmacological treatments are understanding abstract information, due to intellectual disabilities, and deficits in socialization (Fung et al., 2015) . To begin to address the feasibility and efficacy of non-pharmacological therapies in 22q11.2DS, we used a systematic search strategy to identify literature on non-pharmacological interventions of psychiatric disorders in individuals with 22q11.2DS.
| METHODS
We attempted to identify all literature reporting on non-pharmacological . We did not put any language or date restrictions on the search which was completed in the 2nd week of July 2016. We searched for human studies with individuals of all ages, gender, and race/ethnicity. We searched all kinds of publications in journal articles, including research in progress, conference proceedings/abstracts, dissertations, and books. Search terms describing the population of individuals with 22q11.2DS included "22q11.2," "velocardiofacial syndrome," "DiGeorge syndrome," and related terms. Based on a small preliminary search we expected a paucity of relevant literature and we broadened our search terms to all psychiatric disorders and all kinds of non-pharmacological interventions related to psychiatric disorders. The search terms used are presented in the online Supplementary material.
We subsequently came across a relevant study published subsequent to this search and have added this publication to the review (Demily & Franck, 2016 
| RESULTS
The initial search identified 1,240 titles, of which 11 publications (10 in English, one in German) met inclusion criteria. A summary of the publications included in the review, two that refer to the same study, is provided in Table 1 .
| Literature reviews
Five of the 11 identified publications were literature reviews. Four of these referred to standard non-pharmacological interventions of psychiatric disorders in individuals with 22q11.2DS (Bassett et al., 2011; Briegel & Cohen, 2004; Fung et al., 2015; Gothelf, Burg, & Zalevsky, 2013) . The importance of adequate treatment of co-existing somatic conditions was highlighted in the practical guidelines for managing individuals with 22q11.2DS (Bassett et al., 2011; Fung et al., 2015) . The fifth publication reviewed literature on effective interventions in idiopathic schizophrenia and described similarities in the expression of schizophrenia and 22q11.2DS, such as impairments in executive functioning, memory, attention, and social cognition (Demily & Franck, 2016) . The authors proposed the use of CBT and discussed that adaptations may be needed in individuals with 22q11.2DS, though, as for the other reviews, in the absence of original data.
| Original research
Of the 11 identified publications, five reported original research. As the two published abstracts refer to the same study population (Eliez & Glaser, 2015; Eliez et al., 2011) , we focused on the later abstract. Three of these four studies described computerized intervention programs (Eliez & Glaser, 2015; Harrell et al., 2013; Mariano, Tang, Kurtz, & Kates, 2015) and one described a small-group-based program (Shashi et al., 2015) . All four of these original studies aimed at improving neuropsychological deficits that are associated with, and relevant to, the occurrence of psychiatric disorders.
Two of the original studies reported on the feasibility and effects of cognitive remediation (CR), based on the fact that deficits in cognitive functions have been found in individuals with psychotic disorders, and in individuals with 22q11.2DS with and without psychotic illness (Harrell et al., 2013; Mariano et al., 2015) . two did not complete the study due to inconsistent or unreliable internet access and two due to lack of motivation on the part of parents or participants. The authors reported improvements in simple processing speed and on a cognitive composite score in the treatment group when compared with a group of 10 age-matched adolescents with 22q11.2DS who did not receive the intervention. The authors of both of these CR studies concluded that CR is a feasible and effective intervention for individuals with a 22q11.2 deletion.
The study by Eliez et al. (2011) and Eliez and Glaser (2015) reported on the use of a computerized software program they developed, VisAVis, that aims at improving working memory, emotion recognition, and face processing in children and adolescents with intellectual disability. A VisAVis computerized program consists of 12 weeks of 20-25 min sessions four times per week for the individual patient, supervised by an adult (Glaser et al., 2012) . The authors offered this program to 16 children and adolescents with 22q11.2DS, 19 with an autism spectrum disorder, and 14 with developmental delay who served as the comparison (control) group. Improvements in attention and concentration, nonverbal reasoning, and recognition of facial emotional expressions were reported for the 22q11.2DS-group (and for the autism spectrum disorder group), supporting the potential utility of the VisAVis program as a tool for improving socio-emotionalcognitive impairments.
In the only original study of a non-computerized intervention, (Shashi et al., 2015) aimed at improving social cognition and social skills in adolescents with 22q11.2DS, as deficits in these domains had been previously associated with an increased risk for developing serious psychiatric illnesses such as schizophrenia. They adjusted a 26-week, small-group-based program involving cognitive enhancement therapy (CET, Hogarty & Greenwald, 2006) , for a group of 17 adolescents with 22q11.2DS. Two sessions aimed at getting to know each other and providing psychoeducation about 22q11.2DS. Subsequent sessions included, but were not limited to, perspective thinking, awareness, recognition and mediation of emotions, social skills, flexible thinking, and identifying maladaptive thoughts and replacing them with more adaptive thoughts. One adolescent dropped out after two sessions (reason for drop out not reported) and three others were excluded from analyses because of missing post-intervention assessments. The authors reported that the program was feasible, with high rates of compliance and satisfaction on the part of the participants and their families. Their preliminary analyses indicated that the intervention used resulted in significant improvements in an overall social cognitive composite index.
| Other
One of the 11 publications included in our review did not fit into either a review or original research category (Fjermestad, Vatne, & Gjone, 2015) .
While presented as a research paper, no outcome measures, control group, or study results were reported. The hypothesis presented was that established CBT protocols may be challenging to provide to individuals with 22q11.2DS due to their cognitive and social difficulties, 
| DISCUSSION
This systematic review identified five literature reviews, five publications (two of which referred to the same study) reporting original data, and one publication that did not fall into either category. Four of the five literature reviews recommended standard non-pharmacological interventions. One of the reviews and a publication not fitting either category, though not substantiated by scientific evidence, suggested adaptations to standard interventions may be helpful. The four original studies reported on findings from research using promising computerbased and group interventions in individuals with 22q11.2DS. Strikingly, however, this review revealed that no research studying the efficacy and/or feasibility of standard or adjusted non-pharmacological interventions targeting common psychiatric disorders in individuals with 22q11.2DS has been published to date.
The results of this review make it perhaps understandable why standard non-pharmacological management has been recommended for 22q11.2DS (Briegel & Cohen, 2004) , including in the current international practical guidelines for 22q11.2DS (Bassett et al., 2011; Fung et al., 2015; Gothelf et al., 2013) . However, there may be a disconnect between these guidelines and common clinical practice, given the reported under treatment of psychiatric disorders in this patient population (Tang et al., 2014; Young, Shashi, Schoch, Kwapil, & Hooper, 2011) . 22q11.2DS-specific adjustments to standard treatment strategies may be necessary, as proposed in two of the papers included in this study (Demily & Franck, 2016; Fjermestad et al., 2015) , and as is the practice for individuals with an intellectual disability (Idusohan-Moizer, Sawicka, Dendle, & Albany, 2015; Lindsay et al., 2015) .
Four preliminary studies have however investigated interventions targeting deficits in neuropsychological domains of functioning that are associated with expression of psychosis, such as cognitive abilities, and socio-emotional functioning (Eliez & Glaser, 2015 , Harrell et al., 2013 Mariano et al., 2015; Shashi et al., 2015) . Three reported using some sort of control method, including approaches to reduce bias (Harrell et al., 2013; Mariano et al., 2015; Shashi et al., 2015) . Harrell et al. (2013) non-randomly assigned children to a control group and reported no significant differences between the intervention and control groups in age, gender, or race. Shashi et al. (2015) assigned participants who did not live in the vicinity to a control group and matched the intervention and control groups for age, gender, and ethnicity. Mariano et al. (2015) used the intervention group as their own controls. All three of these studies also reported on the feasibility of their intervention and reported substantial adherence rates (Harrell et al., 2013; Mariano et al., 2015; Shashi et al., 2015) . It should however be noted that compensation of 10 dollars per week for participated sessions was provided, something uncommon in clinical practice, and this may have had an impact on adherence rates (Harrell et al., 2013; Mariano et al., 2015; Shashi et al., 2015) . Promising improvements were reported immediately and/or at 12 weeks post-intervention in several domains of neuropsychological functioning, including working memory, attention, and social cognition, in all five of the preliminary studies, despite relatively small sample sizes. | 5
